Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera - CNBC
- Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera CNBC
- Pfizer doubles down on weight-loss treatments with up to $7.3 billion Metsera buyout Yahoo Finance
- Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion The Wall Street Journal
- Metsera Stock Jumps 60% on $7.3 Billion Bid by Pfizer for Anti-Obesity Barron's
- Pfizer to acquire Metsera for $47.50/share in $4.9 billion deal (PFE:NYSE) Seeking Alpha